Literature DB >> 25785024

Differential expression of 5-HT-related genes in symptomatic pulmonary embolism patients.

Yun Jin1, Lemin Wang1, Qianglin Duan1, Zhu Gong1, Fan Yang2, Yanli Song3.   

Abstract

OBJECTIVE: Whole human genome oligo microarrays were employed to systematically investigate the mRNA expression profile of 5-HT synthetase, transporter, receptor, and factors in 5-HT signaling pathway in peripheral blood karyocytes from pulmonary embolism (PE) patients.
METHODS: A total of 20 PE patients and 20 healthy subjects matched in gender and age were recruited. The human genome microarrays were performed to detect the mRNA expression profile of 5-HT synthetase, transporter, receptor, and factors in 5-HT signal pathway of two groups. The random variance model corrected t-test was used for analysis.
RESULTS: Our results showed (1) tryptophan hydroxylase (TPH1)-related gene expression was markedly down-regulated in PE patients (P < 0.01); (2) monoamine oxidases (MAO)-related gene (MAOB) expression was significantly up-regulated in PE patients (P < 0.01); (3) the expression of 17 genes of 7 5-HT receptors showed a down-regulated tendency in PE patients, and significant difference was observed in the expression of HTR1E, HTR3B, HTR4 and HTR5A between them (P < 0.05); (4) the expression of DalDAG-GEF I, Tubby, PKA and EPAC in 5-HT signal pathways was dramatically up-regulated in PE patients (P < 0.05); the expression of SPA1, RIAM, RAPL, Talin, PKC, PLC and Pyk2 was remarkably up-regulated in PE patients (P < 0.05); (5) the expression of integrin genes ITGA2B, ITGB1 and ITGB3 was significantly up-regulated in PE patients (P < 0.05).
CONCLUSION: In PE patients, the expression of TPH1 and HTR4 was down-regulated as a negative feedback; the MAOB expression was up-regulated. Consistent with the expression of 5-HTR1E and 5-HTR4 and the abnormally activated Tubby, the expression of integrins in platelets was activated.

Entities:  

Keywords:  5-HT receptor; Tubby; integrin; mRNA; pulmonary embolism

Year:  2015        PMID: 25785024      PMCID: PMC4358479     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

Review 1.  [Prevention of venous thromboembolism in psychiatry].

Authors:  R Malý; J Masopust; K Konupcíková
Journal:  Vnitr Lek       Date:  2006-03

Review 2.  Molecular, pharmacological and functional diversity of 5-HT receptors.

Authors:  Daniel Hoyer; Jason P Hannon; Graeme R Martin
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

3.  Antipsychotic drug use and the risk of venous thromboembolism in elderly patients with dementia.

Authors:  Niklas Schmedt; Edeltraut Garbe
Journal:  J Clin Psychopharmacol       Date:  2013-12       Impact factor: 3.153

4.  Increased risk for pulmonary embolism in patients with bipolar disorder.

Authors:  Ulla Strudsholm; Line Johannessen; Leslie Foldager; Povl Munk-Jørgensen
Journal:  Bipolar Disord       Date:  2005-02       Impact factor: 6.744

5.  G-protein signaling through tubby proteins.

Authors:  S Santagata; T J Boggon; C L Baird; C A Gomez; J Zhao; W S Shan; D G Myszka; L Shapiro
Journal:  Science       Date:  2001-05-24       Impact factor: 47.728

6.  Human 5-HT(5) receptors: the 5-HT(5A) receptor is functional but the 5-HT(5B) receptor was lost during mammalian evolution.

Authors:  R Grailhe; G W Grabtree; R Hen
Journal:  Eur J Pharmacol       Date:  2001-04-27       Impact factor: 4.432

7.  Fate map of serotonin transporter-expressing cells in developing mouse heart.

Authors:  Luigi Michele Pavone; Pratibha Mithbaokar; Vincenzo Mastellone; Luigi Avallone; Patricia Gaspar; Veeramani Maharajan; Antonio Baldini
Journal:  Genesis       Date:  2007-11       Impact factor: 2.487

8.  Familial risk of venous thromboembolism in first-, second- and third-degree relatives: a nationwide family study in Sweden.

Authors:  Bengt Zöller; Henrik Ohlsson; Jan Sundquist; Kristina Sundquist
Journal:  Thromb Haemost       Date:  2013-01-24       Impact factor: 5.249

9.  Plasma serotonin levels and the platelet serotonin transporter.

Authors:  B Brenner; J T Harney; B A Ahmed; B C Jeffus; R Unal; J L Mehta; F Kilic
Journal:  J Neurochem       Date:  2007-05-15       Impact factor: 5.372

10.  Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.

Authors:  Saloua Benmansour; William A Owens; Marco Cecchi; David A Morilak; Alan Frazer
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  3 in total

1.  Effects of Shen'an granules on Wnt signaling pathway in mouse models of diabetic nephropathy.

Authors:  Xin-Rong Zou; Xiao-Qin Wang; Ying-Lin Hu; Hui-Lan Zhou
Journal:  Exp Ther Med       Date:  2016-10-12       Impact factor: 2.447

2.  A Bioinformatics Model of Human Diseases on the Basis of Differentially Expressed Genes (of Domestic Versus Wild Animals) That Are Orthologs of Human Genes Associated with Reproductive-Potential Changes.

Authors:  Gennady Vasiliev; Irina Chadaeva; Dmitry Rasskazov; Petr Ponomarenko; Ekaterina Sharypova; Irina Drachkova; Anton Bogomolov; Ludmila Savinkova; Mikhail Ponomarenko; Nikolay Kolchanov; Alexander Osadchuk; Dmitry Oshchepkov; Ludmila Osadchuk
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

3.  Association of human serotonin receptor 4 promoter methylation with autism spectrum disorder.

Authors:  Zhenyu Hu; Xiuru Ying; Ling Huang; Yuanzhi Zhao; Dongsheng Zhou; Jing Liu; Jie Zhong; Tianyi Huang; Wenwu Zhang; Fang Cheng; Shiwei Duan
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.